Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00642941
Show Display Options
Rank Status Study
1 Completed A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.
Condition: Sarcoma
Intervention: Drug: RG1507

Indicates status has not been verified in more than two years